{"id":"https://openalex.org/W4361962829","doi":"https://doi.org/10.1158/1078-0432.22488348","title":"Supplementary Information from Efficacy and Safety of the Anti\u2013PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study","display_name":"Supplementary Information from Efficacy and Safety of the Anti\u2013PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study","publication_year":2023,"publication_date":"2023-04-01","ids":{"openalex":"https://openalex.org/W4361962829","doi":"https://doi.org/10.1158/1078-0432.22488348"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22488348","doi":"https://doi.org/10.1158/1078-0432.22488348","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22488348","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22488348","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035395530","display_name":"Jusheng An","orcid":"https://orcid.org/0000-0001-9603-6849","observed_orcids":["https://orcid.org/0000-0001-9603-6849"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jusheng An","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9603-6849","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086734093","display_name":"Jie Tang","orcid":"https://orcid.org/0000-0001-6121-2400","observed_orcids":["https://orcid.org/0000-0001-6121-2400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jie Tang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6121-2400","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110936337","display_name":"Benjamin X. Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin X. Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1453-4359","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022158480","display_name":"Huihua Xiong","orcid":"https://orcid.org/0000-0002-7752-5724","observed_orcids":["https://orcid.org/0000-0002-7752-5724","https://orcid.org/0000-0003-1257-7475","https://orcid.org/0000-0001-8981-1165"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huihua Xiong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7752-5724","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102851236","display_name":"Hui Qiu","orcid":"https://orcid.org/0000-0002-2923-1019","observed_orcids":["https://orcid.org/0000-0002-2923-1019"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hui Qiu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2923-1019","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087018624","display_name":"Lin Luo","orcid":"https://orcid.org/0000-0001-7403-2687","observed_orcids":["https://orcid.org/0000-0001-7403-2687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lin Luo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7403-2687","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045583901","display_name":"Li Wang","orcid":"https://orcid.org/0000-0002-7530-8419","observed_orcids":["https://orcid.org/0000-0002-7530-8419"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7530-8419","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002295761","display_name":"Danbo Wang","orcid":"https://orcid.org/0000-0002-8925-364X","observed_orcids":["https://orcid.org/0000-0002-8925-364X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Danbo Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8925-364X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100650222","display_name":"Qi Zhou","orcid":"https://orcid.org/0000-0001-5673-4263","observed_orcids":["https://orcid.org/0000-0001-5673-4263"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qi Zhou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5673-4263","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030946692","display_name":"Qin Xu","orcid":"https://orcid.org/0000-0002-3689-0266","observed_orcids":["https://orcid.org/0000-0002-3689-0266"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qin Xu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3689-0266","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089967085","display_name":"Honglin Song","orcid":"https://orcid.org/0000-0001-7947-3588","observed_orcids":["https://orcid.org/0000-0001-7947-3588"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Honglin Song","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7947-3588","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052649748","display_name":"Yunyan Zhang","orcid":"https://orcid.org/0000-0003-3352-4241","observed_orcids":["https://orcid.org/0000-0003-3352-4241","https://orcid.org/0000-0001-8254-5730","https://orcid.org/0000-0002-3658-8200"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yunyan Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3352-4241","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100716540","display_name":"Hongping Zhang","orcid":"https://orcid.org/0000-0002-0076-0419","observed_orcids":["https://orcid.org/0000-0002-0076-0419"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hongping Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0076-0419","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034972053","display_name":"Yujie Li","orcid":"https://orcid.org/0000-0002-2325-0390","observed_orcids":["https://orcid.org/0000-0002-2325-0390"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yujie Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2325-0390","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078027427","display_name":"Xiaohui Yu","orcid":"https://orcid.org/0000-0001-9092-4781","observed_orcids":["https://orcid.org/0000-0001-9092-4781"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaohui Yu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9092-4781","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062332505","display_name":"Jing Zhang","orcid":"https://orcid.org/0000-0002-6814-7231","observed_orcids":["https://orcid.org/0000-0002-6814-7231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6814-7231","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011085195","display_name":"Rachel Ng","orcid":"https://orcid.org/0000-0001-6923-6386","observed_orcids":["https://orcid.org/0000-0001-6923-6386"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Ng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6923-6386","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081156660","display_name":"Wayne Zhao","orcid":"https://orcid.org/0000-0002-2896-0746","observed_orcids":["https://orcid.org/0000-0002-2896-0746"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wayne Zhao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2896-0746","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033526988","display_name":"Michael Wong","orcid":"https://orcid.org/0000-0002-1537-7922","observed_orcids":["https://orcid.org/0000-0002-1537-7922"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Wong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1537-7922","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063680131","display_name":"Xiangrong Dai","orcid":"https://orcid.org/0000-0001-7242-1216","observed_orcids":["https://orcid.org/0000-0001-7242-1216"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiangrong Dai","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7242-1216","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100657168","display_name":"Guiling Li","orcid":"https://orcid.org/0000-0002-5663-4585","observed_orcids":["https://orcid.org/0000-0002-5663-4585"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guiling Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5663-4585","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5061667981","display_name":"Lingying Wu","orcid":"https://orcid.org/0000-0003-3153-7786","observed_orcids":["https://orcid.org/0000-0003-3153-7786"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lingying Wu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3153-7786","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.03660000115633011,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-pd-l1-monoclonal-antibody","display_name":"anti-PD-L1 monoclonal antibody","score":0.9919999837875366},{"id":"https://openalex.org/keywords/recurrent-or-metastatic-cervical-cancer","display_name":"recurrent or metastatic cervical cancer","score":0.8949999809265137},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.7799999713897705},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7129999995231628},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.828000009059906},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.3149999976158142},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.9480000138282776}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7716723084449768},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6575547456741333},{"id":"https://openalex.org/C2778220009","wikidata":"https://www.wikidata.org/wiki/Q160105","display_name":"Cervical cancer","level":3,"score":0.564948558807373},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.5501046776771545},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.52366703748703},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.44396787881851196},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41776132583618164},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.41179561614990234},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.411474347114563},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3751849830150604},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.29094645380973816},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17961373925209045},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10692498087882996},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.10082465410232544},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07793048024177551},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22488348","doi":"https://doi.org/10.1158/1078-0432.22488348","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22488348","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22488348.v1","doi":"https://doi.org/10.1158/1078-0432.22488348.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22488348.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Information_from_Efficacy_and_Safety_of_the_Anti_PD-L1_mAb_Socazolimab_for_Recurrent_or_Metastatic_Cervical_Cancer_a_Phase_I_Dose-Escalation_and_Expansion_Study/22488348/1/files/39939966.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22488348","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Information_from_Efficacy_and_Safety_of_the_Anti_PD-L1_mAb_Socazolimab_for_Recurrent_or_Metastatic_Cervical_Cancer_a_Phase_I_Dose-Escalation_and_Expansion_Study/22488348","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22488348","doi":"https://doi.org/10.1158/1078-0432.22488348","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22488348","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361962829.pdf","grobid_xml":"https://content.openalex.org/works/W4361962829.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W1963731933","https://openalex.org/W2085768658","https://openalex.org/W2379493927","https://openalex.org/W4255743485"],"related_works":["https://openalex.org/W4296679200","https://openalex.org/W4361954486","https://openalex.org/W4416627426","https://openalex.org/W4286295749","https://openalex.org/W3209141559","https://openalex.org/W4408802205","https://openalex.org/W4226163554","https://openalex.org/W4362454012","https://openalex.org/W4310924692","https://openalex.org/W4310753923"],"abstract_inverted_index":{"Research":[0],"Protocol":[1],"for":[2],"the":[3,9],"Phase":[4],"I":[5],"Clinical":[6],"Study":[7],"of":[8],"Recombinant":[10],"Fully":[11],"Human":[12],"Anti-PD-L1":[13],"Monoclonal":[14],"Antibody":[15],"Socazolimab":[16]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-05T00:00:00"}